These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5715130)

  • 21. A contribution to the analysis of the mechanism of MSH-induced dispersion in the melanophores of Xenopus laevis.
    van de Veerdonk FC
    Gen Comp Endocrinol; 1969 Jun; 12(3):658-60. PubMed ID: 5769954
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of dopamine to promote spermiation in toads.
    Iturriza FC
    Gen Comp Endocrinol; 1970 Aug; 15(1):180-2. PubMed ID: 4917482
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for a doubly innervated secretory unit in the anuran pars intermedia. I. Electrophysiologic studies.
    Oshima K; Gorbman A
    Gen Comp Endocrinol; 1969 Aug; 13(1):98-107. PubMed ID: 5804513
    [No Abstract]   [Full Text] [Related]  

  • 24. Sensitive method for the bioassay of melanocyte stimulating hormone in human saliva.
    Innes DL; Ritman L; Tansy MF
    J Dent Res; 1974; 53(4):814-20. PubMed ID: 4546332
    [No Abstract]   [Full Text] [Related]  

  • 25. Release of melanocyte stimulating hormone (MSH) from the posterior pituitary lobe incubated in situ after infusion of hypertonic solution into the third cerebral ventricle in rats.
    Mazanowska-Gajdowicz J; Szkudlarek U; Thody J
    Endokrynol Pol; 1985; 36(6):307-13. PubMed ID: 3833534
    [No Abstract]   [Full Text] [Related]  

  • 26. Secretory activity of the intraocular homotransplanted pars intermedia of the frog, Rana nigromaculata.
    Ito T; Yeh WH; Nishiyama K
    Neuroendocrinology; 1986; 43(6):689-95. PubMed ID: 3762865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of change of background colour on the rate of [3H]leucine incorporation and total melanocyte-stimulating hormone content of the pars intermedia of Xenopus laevis.
    Thornton VF; Weatherhead B; Whur P
    J Endocrinol; 1970 Sep; 48(1):xxv-xxvi. PubMed ID: 5472415
    [No Abstract]   [Full Text] [Related]  

  • 28. Electrophysiological correlates of melanocyte-stimulating hormone activity in the frog.
    Denman PM; Miller LH; Sandman CA; Schally AV; Kastin AJ
    J Comp Physiol Psychol; 1972 Jul; 80(1):59-65. PubMed ID: 4557920
    [No Abstract]   [Full Text] [Related]  

  • 29. [Contribution to the method of titration of melanophore stimulating hormone (MSH)].
    STOJAN B; JEZDINSKY J
    Cesk Farm; 1962 Mar; 11():135-8. PubMed ID: 13917360
    [No Abstract]   [Full Text] [Related]  

  • 30. [Action of reserpine in eels. II. Effect on pigmentation and pars intermedia. Comparison with the effect of a black background adaptation].
    Olivereau M
    Z Anat Entwicklungsgesch; 1972; 137(1):30-46. PubMed ID: 4560618
    [No Abstract]   [Full Text] [Related]  

  • 31. Adrenergic receptors and ggeographic variation in Rana pipiens chromatophore responses.
    Hadley ME; Goldman JM
    Am J Physiol; 1970 Jul; 219(1):72-7. PubMed ID: 4393206
    [No Abstract]   [Full Text] [Related]  

  • 32. Release of melanocyte-stimulating hormone from the rat posterior pituitary lobe incubated in situ and from the hypothalamus.
    Cyrkowicz A
    Neuroendocrinology; 1972; 10(4):257-60. PubMed ID: 4653506
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemical quantification of melanophore stimulating substances using polyacrylamide gel disc electrophoresis.
    Preslock JP; Brinkley HJ
    Life Sci; 1970 Feb; 9(4):215-28. PubMed ID: 5435309
    [No Abstract]   [Full Text] [Related]  

  • 34. Adenosine 3',5'-monophosphate (cyclic AMP) as the mediator of the actions of melanocyte stimulating hormone (MSH) and norepinephrine on the frog skin.
    Abe K; Butcher RW; Nicholson WE; Baird CE; Liddle RA; Liddle GW
    Endocrinology; 1969 Feb; 84(2):362-8. PubMed ID: 4303528
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of MSH release in frogs by direct application of L-proplyl-L-leucylglycinamide to the pituitary.
    Kastin AJ; Schally AV; Viosca S
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1437-9. PubMed ID: 5316453
    [No Abstract]   [Full Text] [Related]  

  • 36. D2-like dopamine receptor mediates dopaminergic or gamma-aminobutyric acidergic inhibition of melanotropin-releasing hormone release from the pars intermedia in frogs (Rana nigromaculata).
    Tonosaki Y; Nishiyama K; Honda T; Ozaki N; Sugiura Y
    Endocrinology; 1995 Dec; 136(12):5260-5. PubMed ID: 7588269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. THE SITE OF SYNTHESIS OF THE MELANOPHORE-STIMULATING HORMONE IN THE TROUT PITUITARY.
    BAKER BI
    J Endocrinol; 1965 Jul; 32():397-8. PubMed ID: 14322062
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hypothalamo-hypophysiotrapic hormones. 2].
    Arimura A; Matsuo H; Baba Y
    Tanpakushitsu Kakusan Koso; 1972 Aug; 17(8):620-8. PubMed ID: 4346232
    [No Abstract]   [Full Text] [Related]  

  • 39. [Melanocyte-stimulating hormone].
    Kikuyama S
    Horumon To Rinsho; 1968; 16(1):24-8. PubMed ID: 4877886
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of hypothalamic lesions on the melanocyte stimulating hormone content and histology of the pars intermedia of the rat pituitary gland.
    Howe A; Thody AJ
    J Physiol; 1969 Mar; 201(1):25P-26P. PubMed ID: 5773561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.